JOANN SAMPOLSKI: Open Payments
NPI 1730623216 · NORTHFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,078 in 11 payments from 9 companies in 2025. Trend: 2023 $1,173 · 2024 $1,000 · 2025 $1,078
Food & beverage: $1,078
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $216 |
| Aimmune Therapeutics, Inc. | 2 | $199 |
| Abbott Laboratories | 1 | $135 |
| Neurocrine BioSciences, Inc. | 1 | $116 |
| Otsuka America Pharmaceutical, Inc. | 1 | $108 |
| Axsome Therapeutics, Inc. | 1 | $86 |
| AstraZeneca Pharmaceuticals LP | 1 | $74 |
| Lilly USA, LLC | 1 | $72 |
| Indivior Inc. | 1 | $71 |
Products named: CAPLYTA, ZENPEP, FREESTYLE LIBRE 3, INGREZZA, REXULTI, Auvelity, AIRSUPRA, MOUNJARO.
Industry payments across NJ — which companies pay providers there.
